A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT03735121 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Atezolizumab
DRUG: rHuPH20

Sponsor

Hoffmann-La Roche